HMGB1 serum levels as a potential new biomarker of disease severity in recessive dystrophic epidermolysis bullosa

被引：0
|
作者：
Petrof, G. [1 ]
McGrath, J. [1 ]
机构：
[1] Kings Coll London, St Johns Inst Dermatol, London WC2R 2LS, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2012年 / 166卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：e38 / e38
页数：1
相关论文
共 50 条
  • [21] Characteristics of anemia and its relationship with disease severity in a Spanish cohort of 84 patients with recessive dystrophic epidermolysis bullosa
    Quintana, L.
    Maseda, R.
    Illera, N.
    Crespo, M.
    Butta, N.
    Zuluaga, P.
    Buno, A.
    De Lucas, R.
    Escamez, M.
    Sacedon, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (12) : S202 - S202
  • [22] A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa
    Jean Yuh Tang
    M. Peter Marinkovich
    Eleanor Lucas
    Emily Gorell
    Albert Chiou
    Ying Lu
    Jodie Gillon
    Dipen Patel
    Dan Rudin
    Orphanet Journal of Rare Diseases, 16
  • [23] Disease proteomics reveals modulation of cell microenvironment in recessive dystrophic epidermolysis bullosa
    Kuettner, V.
    Mack, C.
    Rigbolt, K.
    Schilling, O.
    Busch, H.
    Bruckner-Tuderman, L.
    Dengjel, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S45 - S45
  • [24] A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa
    Tang, Jean Yuh
    Marinkovich, M. Peter
    Lucas, Eleanor
    Gorell, Emily
    Chiou, Albert
    Lu, Ying
    Gillon, Jodie
    Patel, Dipen
    Rudin, Dan
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [25] Influence of the second COL7A1 mutation in determining the phenotypic severity of recessive dystrophic epidermolysis bullosa
    Christiano, AM
    McGrath, JA
    Uitto, J
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (04) : 766 - 770
  • [26] Systemic HMGB1 administration ameliorates cutaneous and non-cutaneous manifestations in a dystrophic epidermolysis bullosa model mouse
    Shimbo, T.
    Yamazaki, S.
    Wang, X.
    Kikuchi, Y.
    Bruckner-Tuderman, L.
    Kaneda, Y.
    Tamai, K.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S156 - S156
  • [27] The role of Interleukin-1 driven inflammation in recessive dystrophic epidermolysis bullosa
    Kann, R.
    Anderson-Crannage, M.
    Ascension, A. M.
    Ibanez-Sole, O.
    Zhu, H.
    Schaefer, E.
    Ottomanelli, D.
    Hochberg, B.
    Pan, J.
    Luo, W.
    Tian, M.
    Chu, Y.
    Cairo, M. S.
    Izeta, A.
    Liao, Y.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S350 - S350
  • [28] MMP1 is a major modifier gene in recessive dystrophic epidermolysis bullosa
    Titeux, M.
    Pendaries, V.
    Tonasso, L.
    Decha, A.
    Bodemer, C.
    Hovnanian, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 (03) : 799 - 799
  • [29] Investigating the potential of repurposing diacerein for the treatment of cutaneous wounds in recessive dystrophic epidermolysis bullosa
    Dorfer, S.
    Ablinger, M.
    Wimmer, M.
    Ibrahimpasic, S.
    Illmer, J.
    Bauer, J. W.
    Zauner, R.
    Wally, V.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S363 - S363
  • [30] The potential of adipose-derived stem cells for the treatment of recessive dystrophic epidermolysis bullosa
    Kim, J.
    Hasegawa, T.
    Maeda, Y.
    Wada, A.
    Ikeda, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S239 - S239
12345